Financial Performance - The company's basic earnings per share decreased to 0.1000 yuan in 2024 from 0.2400 yuan in 2023, representing a decline of 58.33% [1] - Net profit fell to 0.35 billion yuan in 2024, down 57.32% from 0.82 billion yuan in 2023 [1] - Operating revenue decreased to 37.41 billion yuan in 2024, an 8.89% drop compared to 41.06 billion yuan in 2023 [1] - The return on equity (ROE) dropped to 1.76% in 2024 from 4.19% in 2023, a decline of 58% [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 46.81 million shares, accounting for 16.61% of the circulating shares, with an increase of 3.61 million shares compared to the previous period [1] - The largest shareholder, Shaoxing Zhenyuan Health Industry Group Co., Ltd., holds 31.23 million shares, representing 11.07% of the total share capital [2] - New entrants among the top shareholders include Wang Chenghua with 2.84 million shares and Zhao Shuiju with 2.14 million shares [2] Dividend Distribution - The company announced a dividend distribution of 0.6 yuan per share (including tax) [3]
浙江震元:2024年报净利润0.35亿 同比下降57.32%